Isotretinoin in Refractory Confluent and Reticulated Papillomatosis (CARP): A Case Series
Journal of Dermatology Research · 2026
DOI: 10.46889/jdr.2026.7101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dermatology Research, 2026. Verfasst von Sapna S Patel und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Importance: Confluent and Reticulated Papillomatosis (CARP) is an uncommon condition that affects young adults and adolescents. Current treatment options have variable results and efficacy, without sustained improvement in some patients.
Objective
To determine whether oral isotretinoin can be an effective treatment for CARP.
Design
Case series of patients with CARP treated with isotretinoin since October 2015.
Setting
Single center outpatient dermatology clinic at an academic medical center.
Participants
Patients seen at our clinic with diagnosis of CARP treated with oral isotretinoin, resulted in 3 patients to review in our study.
Zitieren
APA
Patel, S. S., Nieman, E. L., McShane, D. B., & Morrell, D. S. (2026). Isotretinoin in Refractory Confluent and Reticulated Papillomatosis (CARP): A Case Series. Journal of Dermatology Research. https://doi.org/10.46889/jdr.2026.7101
Vancouver
Patel SS, Nieman EL, McShane DB, Morrell DS. Isotretinoin in Refractory Confluent and Reticulated Papillomatosis (CARP): A Case Series. Journal of Dermatology Research. 2026. doi:10.46889/jdr.2026.7101
BibTeX
@article{Patel2026,
author = {Patel, Sapna S and Nieman, Elizabeth L and McShane, Diana B and Morrell, Dean S},
title = {Isotretinoin in Refractory Confluent and Reticulated Papillomatosis (CARP): A Case Series},
journal = {Journal of Dermatology Research},
year = {2026},
doi = {10.46889/jdr.2026.7101}
}
EUVIMED